Delivery Order SPE2DB22D3004-SPE2DB23FRJ64
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $73K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,983,291 units of Naloxone HCL 4 mg Nasal Spray. The delivery order, valued at $1,845.84, has a firm fixed-price and is expected to be completed by May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,252,687 units of Naloxone HCL 4 mg nasal spray. The contract has a Firm Fixed Price (FFP) pricing type, a ceiling value of $46,516.61, and an ultimate completion date of September 21, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,564,702,663 units of Naloxone HCL 4 mg nasal spray. The contract has a ceiling value of $5,256.12 and is structured as a Firm Fixed Price Delivery Order, running through May 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- This federal contract award, identified as SPE2DB20D3103|SPE2DB23FN0Y8, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,452.65, is for the delivery of 4,560,615,921 units of Naloxone HCl 4 mg Nasal Spray. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is April 18, 2023. The contract is not designated with any set-aside requirements, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,172,804 units of Naloxone HCl 4 mg Nasal Spray. The contract, valued at $7,397.79, is a Firm Fixed Price Delivery Order with a completion date of March 8, 2023. The contract was awarded on March 7, 2023, and there is no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This federal contract award, valued at $2,397.78, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,563,143,368 units of Naloxone HCL 4 mg Nasal Spray, with a completion date of December 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This...
- This federal contract award is for the delivery of 4,559,279,081 units of Naloxone HCL 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2022, with a ceiling value of $2,806.96. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., valued at up to $999,999,999.00 and running...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM0U3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4,563,188,527 units of Naloxone HCl 4 mg Nasal Spray. The contract has a firm fixed price of $2,648.44 and an ultimate completion date of December 28, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,450,602 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Delivery Order with a Firm Fixed Price of $1,855.43 and a completion date of December 27, 2022. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with an ID of SPE2DB22D3016|SPE2DB23FBTL3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,316,293 units of Naloxone HCl 4 mg Nasal Spray, with an ultimate completion date of September 27, 2023 and a ceiling value of $7,341.79. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, is...